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Hyperosmotic-hyperoncotic solutions have been widely used during prehospital care of trauma patients and have shown positive 
hemodynamic effects. Recently, there has been a growing interest in intra-operative use of hypertonic solutions. We reviewed 
30 clinical studies on the use of hypertonic saline solutions during surgeries, with the majority being cardiac surgeries. Reduced 
positive fluid balance, increased cardiac index, and decreased systemic vascular resistance were the main beneficial effects of us-
ing hypertonic solutions in this population. Well-designed clinical trials are highly needed, particularly in aortic aneurysm repair 
surgeries, where hypertonic solutions have shown many beneficial effects. Examining the immunomodulatory effects of hypertonic 
solutions should also be a priority in future studies.
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INTRODUCTION
Most of the clinical experiences to date on the use of 
hypertonic saline have come from trauma patients in the 
prehospital setting or en route to the emergency room.1-3 
The effects of hyperosmotic-hyperoncotic solutions (HHS) 
in rapidly restoring hemodynanic stability, boosting cardiac 
function, and possibly improving outcome, along with a 
demonstrated safety in trauma population, provide the basis 
for the growing interest in their perioperative use over the 
last two decades. The majority of studies were carried out 
in elderly cardiac surgery patients who were at an increased 
risk for intraoperative cardiac complications. The main goals 
of using HHS during the perioperative period are to prevent 
hypovolemia and to assure adequate tissue oxygenation 
while avoiding fluid overload. In this review, we included 
30 studies4-33 of human subjects treated with 7.2-7.5% NaCl 
alone (Hypertonic Saline - HS), NaCl with dextran (HSD) 
or NaCl with hetastarch (HSS). In 15 cases, the fluids were 
administered during cardiac surgeries (table 1). Seven cases 
involved patients undergoing aortic aneurysm repair (table 
2), two cases involved providing tested hypertonic saline in 
neurosurgical patients (table 3), two cases involved patients 
undergoing abdominal hysterectomy (table 4), and four 
cases involved patients who underwent minor operations 
(table 5). Seven studies34-40 tested the hypertonic saline 
using tonicity levels other than those examined previously 
(ranging from 1.8% to 5.85% NaCl) and were among the 
first reported clinical trials on the perioperative use of HS.34 
Two studies41,42 had no control groups, and these studies were 
thus excluded from this review. 
CARDIAC SURGERY 
With the exception of two studies (involving patients 
undergoing cardiac valve surgery) from the group of cardiac 
surgeries,22,31 all clinical experiences were derived from 
coronary artery bypass grafting (CABG) patients. Amongst 
all patients undergoing cardiac surgery, the most relevant 
finding was the substantial decrease in positive fluid balance. 
By titrating volume infusion against pulmonary capillary 
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wedge pressure (PCWP), Oliveira et al.16 while studying the 
effect of HSD in the hemodynamic status of cardiac patients, 
demonstrated an enormous positive fluid balance in the 
control group compared to the HSD group. HSD was being 
tested in regards to it’s effect in the hemodynamic status and 
volume of fluid administrated. The Ringer’s solution group 
required almost 4000 ml more positive fluid balance than the 
control group to arrive at the same hemodynamic status. A 
near zero balance was seen in the HSD group 48 hours after 
surgery. The Tollofsrud study20 also reported a relevant 1200 
ml cumulative spare volume in HHS patients using a 4 ml/
kg of body weight fixed dose. Even when the HHS-treated 
group was compared to the control group, which used colloid 
solutions, administering hypertonic solution was deemed to be 
advantageous.6,7 Furthermore, preoperative hemodilution with 
HHS in patients with normal left ventricular ejection fraction 
who underwent CABG was recently reported to decrease the 
need for perioperative fluid independent of the type of mixed 
colloid used.30 Recently, in a study involving 50 patients 
undergoing cardiac valve surgery, Bueno and colleagues31 
administered 4 ml/kg of HHS before cardiopulmonary bypass 
with a fluid balance of near zero during the first 48 hours as 
compared to a large positive balance in the Ringer’s group. 
Finally, three studies by Jarvela and colleagues25,26,28 stated that 
administering a single dose of 4 ml/kg of 7.5% NaCl over 30 
minutes to CABG patients during the postoperative rewarming 
phase resulted in intense diuretic effects and decreased fluid 
retention. Excess body fluids that had accumulated during 
cardiopulmonary bypass and cardiac surgery were excreted 
because of the increased diuresis in these studies. In one 
study,28 weight gain in the NS - 0.9% Saline control group 
was significantly greater than that in the HS group during the 
first postoperative day (1.9 ± 1.4 kg, median, 2.1 kg and 0.8 ± 
1.5 kg, median, 0.8 kg, respectively; p=0.005). This result 
corroborated observations of decreased fluid retention.
Cardiac index (CI) was another hemodynamic endpoint 
that was favourably altered by hypertonic saline in the 
majority of the studies and was independent of whether 
the solution infusion was titrated. Studies that titrated the 
same infusion as controls showed a substantial increase 
in left ventricular filling pressure.7,16,20 In two studies8,31 
that used a fixed dose, the beneficial effect of increasing 
the CI lasted well into the 48h after surgery. However, by 
administering a single 250 ml postoperative dose of HHS 
and HSD, Sirieix et al.22 verified a transient increase in 
CI that returned to baseline values within 3 hours despite 
significant increases in left ventricular preload and left 
ventricular ejection fraction in their patients. Also, the 
hemodynamic effects of HS lasted only about 1 hour in the 
Jarvela study.25 However, the preoperative hemodilution with 
HSD and HSS in the Molter study30 significantly augmented 
CI. Another important effect of administrating hypertonic 
solutions throughout these studies was the reduction in 
systemic vascular resistance. Three studies8,22,31 reported a 
reduction in pulmonary vascular resistance after infusion 
of HSS or HSD. Regarding mean arterial pressure (MAP), 
most authors observed either a transient increase or no 
significant difference in MAP compared to controls when 
hypertonic solutions were infused. Nevertheless, two studies 
required further attention. In the Prien study,11 a transient 
drop in MAP was documented after infusion of a fixed 
dose of 250 ml HSS over 15 minutes. The 20% decrease in 
MAP from baseline was seen in the first 5 minutes of the 
infusion and was followed by hypervolemic left ventricular 
failure in the majority of these patients. By applying the 
same rate of infusion, Sirieix and colleagues22 managed 
the severe hypotension that developed after hypertonic 
solution administration in three of 16 patients. However, 
they observed significant augmentation of MAP following 
hypertonic solution infusion in the majority of their patients 
compared to those given a control solution. These patients 
also reported significant increase in central venous pressure 
(CVP) following infusion of a hypertonic solution.
In general, the pulmonary function was positively affected 
throughout the studies. There was a statistically significant 
drop in PaO2 in the control groups, while PaO2 remained more 
constant in HSS treated patients.8 Bueno et al.31 reported that 
patients who underwent cardiopulmonary bypass maintained 
a significantly higher PaO2/FiO2 ratio after HSD infusion 
compared to those given Ringer’s solution. Molter et al.30 
described a relevant higher O2 delivery index in the hypertonic 
solution treated group. Furthermore, two additional studies 
demonstrated earlier extubation times after hypertonic saline 
administration.19,31
Hypernatremia was a common finding after using HHS 
in cardiac surgery. However, no neurological symptoms were 
associated with the increased sodium load, even when serum 
sodium reached concentrations of over 160 mmol/L.31
AORTIC ANEURYSM SURGERY
Since the first reported study in 1987 on the use 
of hypertonic saline (7.2-7.5% NaCl) in patients who 
underwent surgical repair of abdominal aortic aneurysm, a 
total of 91 such patients have been treated with hypertonic 
solutions to date. Most of the studies gave HS mixed with 
hydroxyetilhyl starch and had HES as the control solution 
(table 2). The most striking result was the reduced need 
for fluid intake in patients receiving HHS. First, Auler et 
al.4 assessed HS in three abdominal aortic aneurysm AAA 
patients and found a decreased need for perioperative fluid 
despite a slightly greater blood loss in this group in relation 
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to the NS group. More remarkable results were seen in two 
other studies. By preoperatively titrating a bolus of 50 ml of 
HSS to the endpoint of the highest CI at lowest PCWP in 
high risk patients, Ellinger and colleagues14 demonstrated 
an average four-fold decrease in the need for fluid in these 
patients as compared to those in the control group, who were 
given HES. In the Christ study,17 a fixed dose of 250 ml HHS 
was applied during aortic clamping for over 20 minutes and 
resulted in a significantly reduced fluid balance compared to 
the HES-treated control group (2471 ± 949 ml versus 3387 
± 1248 ml). Additional Ringer’s solution was administrated 
in both groups to achieve defined PCWP. Recently, another 
study that titrated dose against the best PCWP/CI ratio 
infused the HSS solution after aortic clamping and reported 
less fluid retention compared to those given an HES solution 
(mean 162 ± 111 ml versus mean 265 ± 108 ml).23 Other 
important effects of HHS on hemodynamic variables were 
also reported. In the Ellinger study,14 the CI nearly doubled 
in patients treated with HSS in a titrated fashion compared 
to that in patients treated with HES. 
Other studies have also demonstrated increased CIs.4,17 
In addition, a decrease in systemic vascular resistance index 
was reported immediately after the infusion of HS4 and after 
administration of HHS during aortic cross-clamping.17 Auler 
Table 1 - Perioperative studies on the use of hypertonic saline (7.2-7.5% NaCl) alone or in association with either dextran 
(HSD) or hydroxielthyl starch (HSS) compared to hydroxiethyl starch (HES), Ringer’s solution (RL), normal saline (NS), 
NS-HSD or polygeline during cardiac surgery
Study by year Solution Dose Control Solution n (solution) n (control)
Boldt et al.6 1990 HSS 4.5ml/Kg HES 10 20
Boldt et al.7 1991 HSS 2.7ml/Kg HES 15 30
Boldt et al.8 1991 HSS 3.1ml/Kg HES 15 15
Boldt et al.9 1991 HSS 3.8ml/Kg HES 15 30
Auler et al.10 1992 HS 4ml/kg NS 10 11
Prien et al.11 1993 HSS 3.5ml/kg HES 18 19
Oliveira et al.16 1995 HSD 235ml RL 10 10
Mazhar et al.19 1998 HS 5ml/kg Polygeline 10 10
Tollofsrud et al.20 1998 HSD 4ml/kg RL 10 10
Sirieix et al.22 1999 HSD/HSS 250ml HES 16 8
Jarvela et al.25 2001 HS 4ml/kg NS 20 20
Jarvela et al.26 2001 16 32 HS 4ml/kg NS/HES 16 32
Jarvela et al.28 2002 HS 4ml/kg NS 36 36
Molter et al.30 2003 HSD/HSS 150ml NS/NS-HES/NS-HSD 16 27
Bueno et al.31 2004 RL 25 25 HSD 4ml/kg RL 25 25
Total 242 303
Table 2 - Perioperative studies on the use of hypertonic saline (7.2-7.5% NaCl) alone or in association with either dextran 
(HSD) or hydroxielthyl starch (HSS) compared to hydroxiethyl starch (HES), Ringer’s solution (RL)/6% Dextran70, or 
normal saline (NS) in aortic aneurysm surgery
Study by Year Solution Dose Control Solution n (solution) n (control)
Auler et al.4 1987 HS 4 ml/kg NS 5 5
Younes et al.5 1988 HS 4 ml/kg NS 18 13
Javanovic et al.12 1995 HSD 4-5 ml/kg RL/6%Dextran70 9 19
Albrecht et al.13 1995 HSS 214 ml HES 11 12
Ellinger et al.14 1995 HSS 2.4 ml/kg HES 20 20
Christ et al.17 1997 HSD/HSS 3.3 ml/kg HES 12 10
Ragaller et al.23 2000 HSS 162 ml HES 16 16
Totals 91 95
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et al.4 also stated that pulmonary vascular resistance soon 
decreased after HS administration.
No hypotension developed in patients receiving HHS, 
regardless of whether the infusion was titrated;14,17 the 
sodium load increased, but no related symptoms were 
reported.17 One anaphylactoid reaction occurred and was 
attributed to HES use.17 One patient died in the Ragaller 
study,23 though it was unclear which group the patient 
belonged to. Three more patients developed serious 
complications in that study, but they were reported to be 
unrelated to fluid therapy.
NEUROSURGERY
Only two intraoperative studies involving neurosurgical 
patients were assessed for this review. While two other 
studies have been published, these two were excluded due 
to both a lack of controls41 and the utilization of 3% NaCl 
solution rather than 7.2-7.5% NaCl solution.39 Hemodynamic 
parameters did not change when HS was used as opposed 
to 20% mannitol in the two excluded studies. Gemma el 
al18 found no difference in brain bulk and cerebrospinal 
fluid (CSF) during elective procedures between infusion of 
a fixed dose of 2.5 ml/kg HS and administration of 2.5 ml/
kg of mannitol. Erard and colleagues29 reported that a single 
infusion of solutions of equal osmolarity, NaCl 7.5% or 
mannitol 20%, induced a similar osmolar variation over time 
in both hypertonic groups.
ABDOMINAL HYSTERECTOMY 
Recently, Kolsen-Petersen and colleagues32,33 published 
two studies on the use of HS in abdominal surgery. Based 
on previous studies in human blood cell cultures43-45 and 
different animals models43,46 that reported that hypertonicity 
is permissive for lymphocyte proliferation43 and restrictive 
for neutrophil function,45,46-50 the researchers observed the 
immunological effects of a fixed dose of HS on postoperative 
women who underwent abdominal hysterectomy. Their 
first randomized double-blind study32 involved 62 women 
who received either 4 ml/kg of 7.5% or 32 ml/kg of 0.9% 
NaCl over 20 min. The study found that an infusion of HS 
saline did not alter the postoperative immune response after 
abdominal hysterectomy. In the subsequent clinical trial 
also by Kolsen-Peterson el al.,33 modest changes from HS 
infusion were observed when compared to normal saline 
treated patients. These changes included a temporary 
increase in the number of B cells in the peripheral blood 
(p<0.01), an augmentation in the concentration of plasma 
elastase (p<0.05), and a decrease in the number of circulating 
neutrophils (p<0.001). 
MINOR SURGERIES/HS FOR PRELOADING 
BEFORE SPINAL ANAESTHESIA
 In a 1995 study demonstrating the inotropic effects of 
HS in anesthetised patients without cardiovascular disease, 
Goertz et al.15 concluded that the apparent improvement of 
left ventricular systolic function in response to hypertonic 
saline/hetastarch was caused mainly by the combined 
effects of increased left ventricular preload and reduced 
left ventricular afterload. Three studies21,24,27 focused on the 
use of HS for preloading before spinal anaesthesia. Two 
of these studies, conducted by Jarvela and colleagues,24,27 
found no significant differences regarding hemodynamic 
parameters and sodium load when the HS-infused group 
Table 3 - Perioperative studies on the use of hypertonic saline (7.2 -7.5% NaCl) alone or in association with either dextran 
(HSD) or hydroxielthyl starch (HSS) compared to 20% mannitol or normal saline (NS) in neurosurgery
Study by Year Solution dose Control Solution n (solution) n (control)
Gemma et al.18 1997 HS 2.5 ml/kg Mannitol 25 25
Erard et al.29 2003 HS 4.95 mOsmkg(-1) Mannitol 10 20
Totals 35 45
Table 4 - Perioperative studies on the use of hypertonic saline (7.2 -7.5% NaCl) compared to normal saline (NS) in abdominal 
hysterectomy
Study by Year Solution dose Control n (solution) n (control)
Kolsen-Petersen et al.32 2004 HS 4 ml/kg NS 21 41
Kolsen-Petersen et al.33 2004 HS 4 ml/kg NS 10 10
Totals 31 51
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was compared to the control group. However, in a separate 
study by Durasnel et al.,21 infusion of 100 ml of HS for over 
15 minutes prior to spinal anaesthesia effectively prevented 
the occurrence of hypotension when directly compared to 
patients infused with normal saline. Hypotension occurred 
in two of 24 patients in the HS group and eight of 24 in the 
NS group (p<0.05). 
COMMENTS 
The improved fluid balance seen in HHS-treated patients 
seems to be the result of various mechanisms. First, after the 
stress and shock of surgery, cells may become edematous.51 
As a result, HHS rapidly shifts fluid from the intracellular 
compartment to the intravascular space with consequent 
plasma expansion.52 HSS increases renal blood flow and 
glomerular filtration rate, induces renal vasodilatation,53 
and decreases plasma aldosterone levels, all resulting in 
increased urine output.54 An immediate increase in urine 
output following HHS administration was observed in 
several cardiac studies.25,26,28,31 In the setting of CPB, 
extracorporeal circulation is particularly related to the release 
of cytokines, vasoactive mediators, hormones and autacoids 
that may cause endothelium damage, increased vascular 
permeability, tissue oedema, and vasoconstriction. Thus, 
fluid accumulation is an expected event during CPB due to 
increased extracellular fluid and intracellular oedema. In 
addition to the fluid shift from erythrocytes and endothelial 
cells, HHS may attenuate the inflammatory response, 
leading to less capillary leakage. In five studies,6-8,16,31 the 
use of hypertonic solution before CPB may have led to a 
better inflammatory profile and accounted for the favourable 
fluid balance. Moreover, hypertonic infusions resulted in 
increased plasma protein55 and decreased protein loss from 
the intravascular space, which may further have positives 
effects on fluid balance. However, analysis of serum protein 
was not the main concern in these studies.
While volume expansion and reduced afterload have 
been accepted as an explanation for the increased CI, the 
direct effects of hypertonic solutions on cardiac contractility 
remain controversial. Most recent results indicated that at 
least a slight effect may exist.56-58 The remarkable increase 
in CI seen in the Ellinger study,14 where HSS was titrated to 
the highest CI at lowest PCWP and suggested that hypertonic 
saline may improve cardiac performance. Only one study 
presented data conflicting with this hypothesis: transient 
hypervolomic left ventricular heart failure was induced by a 
15-minute infusion of HHS in the Prien study.11 This rapid 
HHS infusion rate could be accountable for the transient 
fluid overload seen in their patients. Moreover, severe 
hypotension occurred after a similar rate of administration in 
the Siriex study.22 It is thus generally believed that the degree 
of hypotension is dependent upon the rate of infusion.59 
Therefore, a longer rate of infusion appears to be appropriate 
for intraoperative purposes.
 Numerous reports of reductions in systemic vascular 
resistance index as well as a few reports of decreased 
pulmonary vascular resistance following HHS administration 
were all consistent with the existing established model.60-62
 The most transient hemodynamic effects seen in the 
Javerla studies25-27 could be explained by the strong diuretic 
effects observed immediately after infusion of HS.
The decrease in volume overload along with the 
improved microcirculation and the decreased interstitial 
oedema may be responsible for the more efficient pulmonary 
function observed in several studies.8,20,31 Large volume 
resuscitation with crystalloids worsened lung oedema and 
prolonged the need for mechanical ventilation.63-65 Christ 
et al.17 has suggested that less fluid excess accompanied by 
decreased oedema formation is particularly beneficial for 
high risk patients.
Three studies have shown that a titrated dose was the 
preferred method of administrating hypertonic solution in 
a perioperative setting. The Prien study11 reported a case 
of left ventricular fluid overload caused by a fixed dose 
of 3-4 ml/kg over 15 minutes. Ellinger et al.14 titrated the 
infusion in patients undergoing aortic aneurysm surgery and 
found that a fixed dosage of 4 ml/kg was too high for at-
risk cardiac patients with slight hypovolemia. Furthermore, 
severe hypotension developed after the infusion of a 
Table 5 - Perioperative studies on the use of hypertonic saline 7.2-7.5% NaCl) alone or in association with hydroxielthyl starch 
(HSS) compared to hydroxiethyl starch (HES) or normal saline (NS) in minor surgeries and before spinal anaesthesia
Study by Year Solution dose Control n (solution) n (control)
Goertz et al.15 1995 HSS 4 ml/kg HES 13 13
Durasnel et al.21 1999 HS ±1.5 ml/kg NS 24 24
Jarvela et al.24 2000 HS 1.6 ml/kg NS 20 20
Jarvela et al.27 2001 HS 1.6 ml/kg NS 20 20
Totals 77 77
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fixed 250 ml dose given over 15 minutes in patients who 
underwent cardiac valve repair in the Sirieix study.22 Titrated 
infusion gained further support from animal studies. Pascual 
et al.55 administered titrated doses of HSD in a swine model 
of intra-operative hemorrhagia and found greater volume 
expansion effect of the solution in hypovolemic conditions. 
Furthermore, Nguyen et al.66 reported the advantages of 
titrated resuscitation in haemorrhaged adult sheep. Thus, the 
use of titrated HHS infusion in this population seems to be 
more appropriate.
However, it is clear that certain limitations exist in 
isolated studies of aortic aneurysm repair. First, these 
studies included a small number of patients with little 
synchronization. None of the studies involved more than 
20 patients in the tested groups, which limited the power 
of the statistical analysis. There were also many different 
deficiencies in the study designs and methodologies. Auler 
et al.4 performed a non-randomised study and included 
patients with thoracoabdominal and abdominal aneurysm in 
the experimental group. Furthermore, the studies were not 
blind. Albrecht and colleagues13 examined patients before 
surgery and during the induction of anaesthesia. In the 
Ragaller study,23 the staff was not blinded, which increased 
the possibility of bias once the parameters were defined. 
Furthermore, the studies assessed only a limited number of 
outcome measures. None of the clinical studies considered 
the immunomodulatory effects of hypertonic saline. 
Consistent with the 2002 Cochrane group review67 on the use 
of intravenous fluids (non-blood fluids) for abdominal aortic 
surgery, we also found no overwhelming evidence to support 
or reject the preferential use of any particular type of fluid.
For neurosurgical patients, however, the current shortage 
of studies precluded drawing any conclusions. The lower 
utilization of HS in neurosurgery may be the result of a 
lack of studies as well as study parameters on the safety 
and beneficial effects of using HS.18,29 Despite the similarity 
of the HS dose used by three studies for preloading before 
spinal anaesthesia,21,24,27 only one group reported that infusion 
of the solution was capable of preventing hypotension.21 
These studies used low HS doses, while most clinical trials 
that reported positive effects from HS used higher doses.
The discrepancy between the modest findings reported 
by Kolsen-Petersen et al.32,33 and the results from previous 
studies on the immunomodulatory properties of HS may be 
due to the small number of patients and the characteristics of 
the studied population. Kolsen-Petersen et al. studied healthy 
normovolemic women who underwent a standardized 
surgical procedure. The immunologic response to trauma 
depended heavily on the amount of tissue injury68 and 
blood loss.69 Ischemic reperfusion injury seen in abdominal 
aortic aneurysm repair is another important cause of 
inflammatory response.70 However, as mentioned earlier, 
CPB during cardiac surgery was also associated with further 
inflammation. Based on these results, patients undergoing 
aortic aneurysm repair (particularly ruptured aortic aneurysm 
repair) appear to be the population that experiences the most 
beneficial effects from hypertonic solutions.
The use of colloids along with hypertonic saline prolongs 
volume expansion and may also positively influence 
cardiac function. However, colloids are also linked to a 
small but significant number of complications, particularly 
anaphylactic reactions and changes in coagulation function. 
An anaphylactic reaction in one patient was attributed to 
HES use in the Christ study.17 In two other studies,16,20 
drainages from the chest were slightly greater in the HSD 
groups, but the difference was not statistically significant. 
CONCLUSION
Our analysis of 30 published clinical studies on the 
perioperative use of hypertonic saline (7.2-7.5% NaCl) 
solutions has shown that administration of the hypertonic 
solution resulted in beneficial hemodynamic effects, 
particularly during cardiac surgery. The previously observed 
reductions in positive fluid balance, increases in CI and 
decreases in systemic vascular resistance further supported 
our recommendation of HS use during surgery. Furthermore, 
our study further indicated that dose administration should 
be titrated and that the rate of infusion should be slow. This 
review also demonstrated the urgent need for well-designed 
randomized clinical trials, particularly in the setting of aortic 
aneurysm repair, where HS has shown many beneficial 
effects. The immunomodulatory effects of HS should also 
be a priority in future studies.
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